Asthma Trials

Asthma Trial: Observational study of patients with a diagnosis of asthma and/or COPD (observation period of 3 years)

Nov 27, 2017 by Corporate

a. Subjects ≥12 years of age with a confirmed or suspected diagnosis of asthma or COPD b. Observational study only (no study medications)

Continue Reading

Asthma Trial: Pediatric 6-12 years with persistent, uncontrolled asthma (treatment period of 52 weeks)

Nov 27, 2017 by Corporate

a. Subjects 6-12 years of age with persistent asthma for at least 12 months b. At least 3 months of therapy on medium-dose inhaled corticosteroids plus a second asthma controller or high-dose inhaled corticosteroids alone c. One or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids

Continue Reading

Asthma Trial: Patients with severe, uncontrolled asthma (treatment period of 24 weeks)

Nov 27, 2017 by Corporate

a. Subjects 18-75 years of age with severe asthma requiring medium to high-dose inhaled corticosteroids plus a second asthma controller in the previous 12 months b. Two or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids c. Pre-screening FEV1 <80% of predicted d. Current smokers and ex-smokers with >10 pack-year

Continue Reading

Asthma Trial: Patients with severe, uncontrolled asthma (treatment period of 52 weeks)

Oct 28, 2016 by Corporate

a. Subjects ≥12 years of age with severe asthma requiring medium to high-dose inhaled corticosteroids plus a second or third asthma controller b. Two or more asthma exacerbations in the previous 12 months requiring treatment with systemic corticosteroids c. FEV1 of ≥40% and ≤80% (≤90% for patients aged 12-18 years) d. Current smokers and ex-smokers

Continue Reading